A dermatotoxicokinetic model of human exposures to jet fuel

Toxicological Sciences

Volumn 93, Issue 1, 2006, Pages 22-33

  Kim, David ^a   Andersen, Melvin E ^b   Nylander French, Leena A ^a  

^a IL   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

Exposure assessment; Jet fuel; Skin; Toxicokinetics

Indexed keywords

ALIPHATIC COMPOUND; AROMATIC COMPOUND; FUEL;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY DISTRIBUTION; DISEASE MODEL; ELIMINATION REACTION; EPIDERMIS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; RISK FACTOR; SKIN ABSORPTION; SKIN SURFACE; SKIN TOXICITY; STRATUM CORNEUM; SYSTEMIC CIRCULATION; TOXICOKINETICS; TOXIN ANALYSIS; VOLUNTEER;

ADULT; FEMALE; HUMANS; HYDROCARBONS; MALE; MODELS, THEORETICAL; MONTE CARLO METHOD; OCCUPATIONAL EXPOSURE; SKIN;

EID: 33747877961     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl048     Document Type: Article

References (59)

1. Andersen, M. E. (1991). Physiological modelling of organic compounds. Ann. Occup. Hyg. 35, 309-321.
2. Andersen, M. E., Sarangapani, R., Reitz, R. H., Gallavan, R. H., Dobrev, I. D., and Plotzke, K. P. (2001). Physiological modeling reveals novel pharmacokinetic behavior for inhaled octamethylcyclotetrasiloxane in rats. Toxicol. Sci. 60, 214-231.
3. Agency for Toxic Substances and Disease Registry (1995). Toxicological profile for naphthalene, 1-methylnaphthalene, and 2-methylnaphthalene. U.S. Department of Health and Human Services, U.S. Public Health Service, Atlanta, GA.
4. Boderke, P., Schittkowski, K.,Wolf, M., and Merkle, H. P. (2000). Modeling of diffusion and concurrent metabolism in cutaneous tissue. J. Theor. Biol. 204, 393-407.
5. Bronaugh, R. L., and Maibach, H. I. (1999). Percutaneous absorption drugs - cosmetics - mechanisms - methodology. Dekker, New York.
6. Buckpitt, A., and Bahnson, L. (1986). Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41, 333-341.
7. Cardinali, F. L., Ashley, D. L.,Wooten, J. V., McCraw, J. M., and Lemire, S.W. (2000). The use of solid-phase microextraction in conjunction with a benchtop quadrupole mass spectrometer for the analysis of volatile organic compounds in human blood at the low parts-per-trillion level. J. Chromatogr. Sci. 38, 49-54.
8. Chao,Y. C., Gibson, R. L., and Nylander-French, L. A. (2005). Dermal exposure to jet fuel (JP-8) in US Air Force personnel. Ann. Occup. Hyg. 49, 639-645.
9. Chao, Y. C., Kupper, L. L., Serdar, B., Egeghy, P. P., Rappaport, S. M., and Nylander-French, L. A. (2006). Dermal exposure to jet fuel JP-8 significantly contributes to the production of urinary naphthols in fuel-cell maintenance workers. Environ. Health Perspect. 114, 182-185.
10. Chao, Y. C., and Nylander-French, L. A. (2004). Determination of keratin protein in a tape-stripped skin sample from jet fuel exposed skin. Ann. Occup. Hyg. 48, 65-73.
11. Davies, B., and Morris, T. (1993). Physiological parameters in laboratory animals and humans. Pharm. Res. 10, 1093-1095.
12. Fenske, R. A. (1993). Dermal exposure assessment technique. Ann. Occup. Hyg. 37, 687-706.
13. Fent, K. W., Jayaraj, K., Gold, A., Ball, L. M., and Nylander-French, L. A. (2006). Tape-strip sampling for measuring dermal exposure to 1,6-hexamethylene diisocyanate. Scand J. Work Environ. Health 32, 225-240.
14. Frasch, H. F., and Barbero, A. M. (2003). Steady-state flux and lag time in the stratum corneum lipid pathway: Results from finite element models. J. Pharm. Sci. 92, 2196-2207.
15. Goffe, W. L., Ferrier, G. D., and Rojers, J. (1994). Global optimization of statistical functions with simulated annealing. J. Econom. 60, 65-99.
16. Guy, R. H., Hadgraft, J., and Maibach, H. I. (1985). Percutaneous absorption in man: A kinetic approach. Toxicol. Appl. Pharmacol. 78, 123-129.
17. Jacobi, U., Weigmann, H. J., Ulrich, J., Sterry, W., and Lademann, J. (2005). Estimation of the relative stratum corneum amount removed by tape stripping. Skin Res. Technol. 11, 91-96.
18. Kim, D., Andersen, M. E., and Nylander-French, L. A. (2006). Dermal absorption and penetration of jet fuel components in humans. Toxicol. Lett. 165, 11-21.
19. Klaassen, C. D. (1996). Casarett and Doull's Toxicology: The Basic Science of Poisons. McGraw-Hill, New York.
20. Levitt, D. G. (2002). PKQuest: A general physiologically based pharmacokinetic model. Introduction and application to propranolol. BMC Clin. Pharmacol. 2, 5.
21. Loden, M., Akerstrom, U., Lindahl, K., and Berne, B. (2004). Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration. Int. J. Pharm. 284, 23-30.
22. Loffler, H., Dreher, F., and Maibach, H. I. (2004). Stratum corneum adhesive tape stripping: Influence of anatomical site, application pressure, duration and removal. Br. J. Dermatol. 151, 746-752.
23. Madison, K. C. (2003). Barrier function of the skin: "la raison d'etre"' of the epidermis. J. Invest. Dermatol. 121, 231-241.
24. Marks, R. (2004). The stratum corneum barrier: The final frontier. J. Nutr. 134, 2017S-2021S.
25. McCarley, K. D., and Bunge, A. L. (2001). Pharmacokinetic models of dermal absorption. J. Pharm. Sci. 90, 1699-1719.
26. McDougal, J. N., and Boeniger, M. F. (2002). Methods for assessing risks of dermal exposures in the workplace. Crit. Rev. Toxicol. 32, 291-327.
27. McDougal, J. N., Pollard, D. L., Weisman, W., Garrett, C. M., and Miller, T. E. (2000). Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicol. Sci. 55, 247-255.
28. McDougal, J. N., and Robinson, P. J. (2002). Assessment of dermal absorption and penetration of components of a fuel mixture (JP-8). Sci. Total Environ. 288, 23-30.
29. Mitragotri, S. (2003). Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J. Control Release 86, 69-92.
30. Muhammad, F., Brooks, J. D., and Riviere, J. E. (2004). Comparative mixture effects of JP-8(100) additives on the dermal absorption and disposition of jet fuel hydrocarbons in different membrane model systems. Toxicol. Lett. 150, 351-365.
31. Nylander-French, L. A. (2000). A tape-stripping method for measuring dermal exposure to multifunctional acrylates. Ann. Occup. Hyg. 44, 645-651.
32. Nylander-French, L. A. (2003). Occupational dermal exposure assessment. In Patty's Industrial Hygiene (R. Harrison, Ed.). John Wiley & Sons, Inc, New York.
33. Perleberg, U. R., Keys, D. A., and Fisher, J. W. (2004). Development of a physiologically based pharmacokinetic model for decane, a constituent of jet propellant-8. Inhal. Toxicol. 16, 771-783.
34. Pershing, L. K., Bakhtian, S., Poncelet, C. E., Corlett, J. L., and Shah, V. P. (2002). Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources. J. Pharm. Sci. 91, 1312-1323.
35. Pershing, L. K., Nelson, J. L., Corlett, J. L., Shrivastava, S. P., Hare, D. B., and Shah, V. P. (2003). Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products. J. Am. Acad. Dermatol. 48, 740-751.
36. Pinheiro, J. C., and Bates, D. M. (2000). Mixed-Effects Models in S and S-Plus. Springer-Verlag, Inc, New York.
37. Pirot, F., Kalia, Y. N., Stinchcomb, A. L., Keating, G., Bunge, A., and Guy, R. H. (1997). Characterization of the permeability barrier of human skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 94, 1562-1567.
38. Poet, T. S., and McDougal, J. N. (2002). Skin absorption and human risk assessment. Chem. Biol. Interact. 140, 19-34.
39. Qiao, G. L., Chang, S. K., Brooks, J. D., and Riviere, J. E. (2000). Dermatoxicokinetic modeling of p-nitrophenol and its conjugation metabolite in swine following topical and intravenous administration. Toxicol. Sci. 54, 284-294.
40. Reddy, M. B., Stinchcomb, A. L., Guy, R. H., and Bunge, A. L. (2002). Determining dermal absorption parameters in vivo from tape strip data. Pharm. Res. 19, 292-298.
41. Rothenberg, T. J. (1971). Identification in parametric models. Econometrica 39, 577-591.
42. Rustemeier, K., Stabbert, R., Haussmann, H. J., Roemer, E., and Carmines, E. L. (2002). Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food Chem. Toxicol. 40, 93-104.
43. Sartorelli, P. (2002). Dermal exposure assessment in occupational medicine. Occup. Med. (Lond.) 52, 151-156.
44. Sartorelli, P., Aprea, C., Cenni, A., Novelli, M. T., Orsi, D., Palmi, S., and Matteucci, G. (1998). Prediction of percutaneous absorption from physicochemical data: A model based on data of in vitro experiments. Ann. Occup. Hyg. 42, 267-276.
45. Schneider, T., Cherrie, J.W., Vermeulen, R., and Kromhout, H. (2000). Dermal exposure assessment. Ann. Occup. Hyg. 44, 493-499.
46. Semple, S. (2004). Dermal exposure to chemicals in the workplace: Just how important in skin absorption? Occup. Environ. Med. 61, 376-382.
47. Semple, S. (2005). Assessing occupational and environmental exposure. Occup. Med. (Lond.) 55, 419-424.
48. Serdar, B., Egeghy, P. P., Gibson, R., and Rappaport, S. M. (2004). Dose-dependent production of urinary naphthols among workers exposed to jet fuel (JP-8). Am. J. Ind. Med. 46, 234-244.
49. Serdar, B., Egeghy, P. P., Waidyanatha, S., Gibson, R., and Rappaport, S. M. (2003). Urinary biomarkers of exposure to jet fuel (JP-8). Environ. Health Perspect. 111, 1760-1764.
50. Shah, V. P. (2001). Progress in methodologies for evaluating bioequivalence of topical formulations. Am. J. Clin. Dermatol. 2, 275-280.
51. Shatkin, J. A., and Brown, H. S. (1991). Pharmacokinetics of the dermal route of exposure to volatile organic chemicals in water: A computer simulation model. Environ. Res. 56, 90-108.
52. Slob,W., Janssen, P. H., and van den Hof, J. M. (1997). Structural identifiability of PBPK models: Practical consequences for modeling strategies and study designs. Crit. Rev. Toxicol. 27, 261-272.
53. Subcommittee on Jet-Propulsion Fuel 8 (2003). Toxicologic Assessment of Jet-Propulsion Fuel 8. The National Academies Press, Washington, DC.
54. Surber, C., Schward, F. P., and Fmith, E.W. (1999). Tape stripping technique. In Percutaneous Absorption-Drug-Cosmetics-Mechanisms-Methodology (H.Bronough and H. I. Maibach, Eds.), pp. 395-409. Marcel Dekker, New York.
55. U.S. EPA (1998). Toxicological Review of Naphthalene. U.S. Environmental Protection Agency, Washington, DC.
56. Waidyanatha, S., Zheng, Y., and Rappaport, S. M. (2003). Determination of polycyclic aromatic hydrocarbons in urine of coke oven workers by headspace solid phase microextraction and gas chromatography-mass spectrometry. Chem. Biol. Interact. 145, 165-174.
57. Willems, B. A. T., Melnick, R. L., Kohn, M. C., and Portier, C. J. (2001). A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice. Toxicol. Appl. Pharmacol. 176, 81-91.
58. Williams, P. L., and Riviere, J. E. (1995). A biophysically based dermatopharmacokinetic compartment model for quantifying percutaneous penetration and absorption of topically applied agents. I. Theory. J. Pharm. Sci. 84, 599-608.
59. AEgis Technologies Group Inc. (2004). acslXtreme Optimum user's guide version 1.4. Huntsville, AL.